Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. 3i Group plc
  6. News
  7. Summary
    III   GB00B1YW4409

3I GROUP PLC

(III)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 01/20 08:51:23 am
1404.5 GBX   -0.39%
01/18Kepler Cheuvreux Maintains 3i At Buy, Lifts PT
MT
01/14The latest from London: Investors shrug off GDP news
20213I GROUP PLC : Monthly statement on outstanding equity shares and voting rights
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

3i : backed Cirtec diversifies with acquisition of Metrigraphics

01/03/2019 | 05:19am EST
03 Jan 2019

3i Group plc ('3i') today announces that Cirtec Medical ('Cirtec'), a strategic outsourcing partner for complex medical devices in which 3i invested in August 2017, is acquiring Metrigraphics, a leading manufacturer of ultra-high precision, custom micron-scale circuits and components for the medical devices industry and other critical applications.

Metrigraphics combines core technologies of thin film sensor substrate manufacturing with their proprietary processes to provide ultra-miniature components that increase the performance, accuracy, and reliability of state-of-the-art medical and wearable devices. The Company serves a number of fast growing medical device segments, including continuous glucose monitoring, advanced drug delivery, active medication management and life science instruments. The acquisition also further strengthens Cirtec's relationship with market leading and pioneering OEMs serving these device segments.

Metrigraphics has approximately 175 employees. The company is ISO 9001 certified and is based in a 46,000 sq. ft. facility in Lowell, Massachusetts.

Brian Highley, CEO, Cirtec, commented:

'This is a significant acquisition that fits perfectly with Cirtec's focus on active implantables and aligns well with our strategy of expanding our capabilities serving minimally invasive interventional therapeutic products. We plan to continue to enhance our capabilities to support our core customers, including those in the neuromodulation and active implantable markets, and to increase our investment in wearables and other biomedical applications.'

Richard Relyea, Partner, 3i Private Equity, added:

'The acquisition of Metrigraphics builds upon the recent acquisition of Cactus Semiconductor and further expands the company's product portfolio of cutting edge and technically challenging medical device components. Metrigraphics also diversifies the company's device exposures with additional therapeutic markets poised for long-term growth. We are excited to partner with an organisation that has such strong capabilities and relationships with innovative OEMs.'

This transaction represents Cirtec's fourth completed acquisition since 3i's investment, and will be funded from the company's own resources.

-Ends-

Download this press release

For further information, contact:

3i Group plc

Notes to editors:

About 3i Group

3i is a leading international investment manager focused on mid-market private equity and infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

About Cirtec

For over 30 years, Cirtec has been providing design, development, manufacturing, and product transfer services to the medical device industry. With facilities in Brooklyn Park, MN; Chandler, AZ; Enfield, CT; Los Gatos, CA, and Birkenfeld, Germany, the company specialises in outsourcing solutions for active implantable devices in the areas of neuromodulation, drug delivery, cardiac rhythm management, mechanical circulatory support, and minimally invasive surgical devices. For more information on Cirtec, please visit http://cirtecmed.com

Disclaimer

3i Group plc published this content on 03 January 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 03 January 2019 10:18:08 UTC


ę Publicnow 2019
All news about 3I GROUP PLC
01/18Kepler Cheuvreux Maintains 3i At Buy, Lifts PT
MT
01/14The latest from London: Investors shrug off GDP news
20213I GROUP PLC : Monthly statement on outstanding equity shares and voting rights
CO
2021GLOBAL MARKETS LIVE : Oracle, Pfizer, Tesla, Amgen, Royal Dutch Shell...
2021EUROPEAN MIDDAY BRIEFING - Stocks, Oil Prices -2-
DJ
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures, -3-
DJ
2021Rio Tinto Names Dominic Barton Board Chair
MT
2021Omicron, Magellan Financial drag Australian shares lower
RE
2021DOMINIC BARTON : Stocks To Slide as Market Worries Mount
DJ
2021Rio Tinto Hires Canadian Ambassador to China as Next Chairman
MT
More news
Analyst Recommendations on 3I GROUP PLC
More recommendations
Financials
Sales 2022 3 673 M 4 999 M 4 999 M
Net income 2022 3 435 M 4 675 M 4 675 M
Net Debt 2022 797 M 1 084 M 1 084 M
P/E ratio 2022 4,24x
Yield 2022 2,92%
Capitalization 13 635 M 18 584 M 18 557 M
EV / Sales 2022 3,93x
EV / Sales 2023 5,43x
Nbr of Employees 234
Free-Float -
Chart 3I GROUP PLC
Duration : Period :
3i Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends 3I GROUP PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 1 410,00 GBX
Average target price 1 653,86 GBX
Spread / Average Target 17,3%
EPS Revisions
Managers and Directors
Simon Alexander Borrows Chief Executive Officer & Executive Director
Julia Susan Wilson Group Finance Director & Executive Director
David Alexander M Hutchison Non-Executive Chairman
Jasi Hari Halai Group Operating Officer & Financial Controller
John Decesare Director-Group Compliance
Sector and Competitors
1st jan.Capi. (M$)
3I GROUP PLC-2.69%18 584
BLACKROCK, INC.-9.84%125 216
BROOKFIELD ASSET MANAGEMENT INC.-8.95%86 364
UBS GROUP AG7.55%66 474
BANK OF NEW YORK MELLON CORPORATION (THE)2.00%47 638
APOLLO GLOBAL MANAGEMENT, INC.-6.60%40 230